Mesirow Financial Investment Management, Inc. Halozyme Therapeutics, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.94 Billion
- Q3 2024
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 8,500 shares of HALO stock, worth $469,880. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,500
Previous 8,500
-0.0%
Holding current value
$469,880
Previous $445,000
9.21%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
538Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$974 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$713 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$367 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$225 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$188 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.7B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...